Not exact matches
By contrast, while the cost of older, branded pharmaceuticals continue to rise and contribute to
increased spending,
when discounting is considered,
prices of these
drugs increased, on average, 2.8 % in 2015, the lowest growth rate in years.
Novum has steadily
increased its
price since that time,
when it acquired the
drug from Primus Pharmaceuticals, its previous owner.
In fact,
when pressed on the issue, Verheul speculated that perhaps costs would not
increase since Canadians already pays higher
prices for pharmaceutical
drugs than consumers in European countries such as the UK, France or Germany.
The market selloff in biotech began last year
when Hilary Clinton commented on
drug price gouging and the need for
increased regulation.